References

Abildgaard U, Heimdal K Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013; 166:(2)117-23 https://doi.org/10.1016/j.ejogrb.2012.09.026

Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014; 63:(18)1815-22 https://doi.org/10.1016/j.jacc.2014.02.529

Azzam HAG, Abousamra NK, Goda H, El-Shouky R, El-Gilany AH The expression and concentration of CD40 ligand in normal pregnancy, pre-eclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome. Blood Coagul Fibrinolysis. 2013; 24:(1)71-5 https://doi.org/10.1097/MBC.0b013e32835a8aca

Biino G, Santimone I, Minelli C, Sorice R, Frongia B, Traglia M, Ulivi S, Di Castelnuovo A, Gögele M, Nutile T, Francavilla M, Sala C, Pirastu N, Cerletti C, Iacoviello L, Gasparini P, Toniolo D, Ciullo M, Pramstaller P, Pirastu M, de Gaetano G, Balduini CL Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects’ data. PLoS One. 2013; 8:(1) https://doi.org/10.1371/journal.pone.0054289

Boehlen F Thrombocytopenia during pregnancy. Importance, diagnosis and management. Hamostaseologie. 2006; 26:(1)72-4

Burke N, Flood K, Murray A, Cotter B, Dempsey M, Fay L, Dicker P, Geary MP, Kenny D, Malone FD Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study. BJOG. 2013; 120:(13)1599-604 https://doi.org/10.1111/1471-0528.12394

Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, Harper A, Hulbert D, Lucas S, McClure J, Millward-Sadler H, Neilson J, Nelson-Piercy C, Norman J, O’Herlihy C, Oates M, Shakespeare J, de Swiet M, Williamson C, Beale V, Knight M, Lennox C, Miller A, Parmar D, Rogers J, Springett A Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011; 118:1-203 https://doi.org/10.1111/j.1471-0528.2010.02847.x

Dadhich S, Agrawal S, Soni M, Choudhary R, Jain R, Sharma S, Saini SL Predictive value of platelet indices in development of preeclampsia. Journal of South Asian Federation of Obstetrics and Gynaecology. 2012; 4:(1)17-21 https://doi.org/10.5005/jp-journals-10006-1164

Dundar O, Yoruk P, Tutuncu L, Erikci AA, Muhcu M, Ergur AR, Atay V, Mungen E Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia. Prenat Diagn. 2008; 28:(11)1052-6 https://doi.org/10.1002/pd.2126

Ferrari S, Palavra K, Gruber B, Kremer Hovinga JA, Knöbl P, Caron C, Cromwell C, Aledort L, Plaimauer B, Turecek PL, Rottensteiner H, Scheiflinger F Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura. Haematologica. 2014; 99:(4)779-87 https://doi.org/10.3324/haematol.2013.094151

Fisher SJ Why is placentation abnormal in pre-eclampsia?. Am J Obstet Gynecol. 2015; 213:(4, Suppl)S115-22 https://doi.org/10.1016/j.ajog.2015.08.042

Freitas LG, Sathler-Avelar R, Vitelli-Avelar DM, Bela SR, Teixeira-Carvalho A, Carvalho Md, Martins-Filho OA, Dusse LM Pre-eclampsia: Integrated network model of platelet biomarkers interaction as a tool to evaluate the hemostatic/immunological interface. Clin Chim Acta. 2014; 436:193-201 https://doi.org/10.1016/j.cca.2014.05.020

Gauer RL, Braun MM Thrombocytopenia. Am Fam Physician. 2012; 85:(6)612-22

George JN Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica. 2009; 94:(6)759-62 https://doi.org/10.3324/haematol.2009.007674

Gernsheimer T, James AH, Stasi R How I treat thrombocytopenia in pregnancy. Blood. 2013; 121:(1)38-47 https://doi.org/10.1182/blood-2012-08-448944

Gerth J, Schleussner E, Kentouche K, Busch M, Seifert M, Wolf G Pregnancy-associated thrombotic thrombocytopenic purpura. J Thromb Haemost. 2009; 101:(2)248-51

Han L, Liu X, Li H, Zou J, Yang Z, Han J, Huang W, Yu L, Zheng Y, Li L Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for pre-eclampsia. PLoS One. 2014; 9:(12) https://doi.org/10.1371/journal.pone.0114488

Haram K, Svendsen E, Abildgaard U The HELLP syndrome: Clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009; 9:(1) https://doi.org/10.1186/1471-2393-9-8

Hedengran KK, Andersen MR, Stender S, Szecsi PB Large D-dimer fluctuation in normal pregnancy: a longitudinal cohort study of 4,117 samples from 714 healthy Danish women. Obstet Gynecol Int. 2016; 2016:1-7 https://doi.org/10.1155/2016/3561675

Hovinga JAK, Vesely SK, Terrell DR, Lämmle B, George JN Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010; 115:(8)1500-11 https://doi.org/10.1182/blood-2009-09-243790

Hui C, Lili M, Libin C, Rui Z, Fang G, Ling G, Jianping Z Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases. Arch Gynecol Obstet. 2012; 285:(5)1231-6 https://doi.org/10.1007/s00404-011-2137-x

Hulstein JJ, van Runnard Heimel PJ, Franx A, Lenting PJ, Bruinse HW, Silence K, de Groot PG, Fijnheer R Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. J Thromb Haemost. 2006; 4:(12)2569-75 https://doi.org/10.1111/j.1538-7836.2006.02205.x

Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014; 123:(11)1674-80 https://doi.org/10.1182/blood-2013-11-538900

Karlsson O, Jeppsson A, Hellgren M A longitudinal study of Factor XIII activity, fibrinogen concentration, platelet count and clot strength during normal pregnancy. Thromb Res. 2014; 134:(3)750-2 https://doi.org/10.1016/j.thromres.2014.07.005

Kasai J, Aoki S, Kamiya N, Hasegawa Y, Kurasawa K, Takahashi T, Hirahara F Clinical features of gestational thrombocytopenia difficult to differentiate from immune thrombocytopenia diagnosed during pregnancy. J Obstet Gynaecol Res. 2015; 41:(1)44-9 https://doi.org/10.1111/jog.12496

Kawaguchi S, Yamada T, Takeda M, Nishida R, Yamada T, Morikawa M, Minakami H Changes in d-dimer levels in pregnant women according to gestational week. Pregnancy Hypertens. 2013; 3:(3)172-7

Kirkpatrick CA The HELLP syndrome. Acta Clin Belg. 2010; 65:(2)91-7 https://doi.org/10.1179/acb.2010.020

Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk JJ Saving Lives, Improving Mothers’ Care – Lessons learned to inform future maternity care from the UK and Ireland Con dential Enquiries into Maternal Deaths and Morbidity 2009–12.(eds.). Oxford: National Perinatal Epidemiology Unit; 2014

Leeners B, Neumaier-Wagner PM, Kuse S, Mütze S, Rudnik-Schöneborn S, Zerres K, Rath W Recurrence risks of hypertensive diseases in pregnancy after HELLP syndrome. J Perinat Med. 2011; 39:(6)673-8 https://doi.org/10.1515/jpm.2011.081

Lin S, Leonard D, Co MA, Mukhopadhyay D, Giri B, Perger L, Beeram MR, Kuehl TJ, Uddin MN Pre-eclampsia has an adverse impact on maternal and fetal health. Transl Res. 2015; 165:(4)449-63 https://doi.org/10.1016/j.trsl.2014.10.006

Linden MD Platelet Physiology. Methods Mol Biol. 2013; 992:13-30 https://doi.org/10.1007/978-1-62703-339-8_2

Loustau V, Debouverie O, Canoui-Poitrine F, Baili L, Khellaf M, Touboul C, Languille L, Loustau M, Bierling P, Haddad B, Godeau B, Pourrat O, Michel M Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol. 2014; 166:(6)929-35 https://doi.org/10.1111/bjh.12976

Mao M, Chen C Corticosteroid therapy for management of hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome: a meta-analysis. Med Sci Monit. 2015; 21:3777-83 https://doi.org/10.12659/MSM.895220

Matsubara K, Higaki T, Matsubara Y, Nawa A Nitric oxide and reactive oxygen species in the pathogenesis of pre-eclampsia. Int J Mol Sci. 2015; 16:(3)4600-14 https://doi.org/10.3390/ijms16034600

McCrae KR Thrombocytopenia in Pregnancy. Hematology. 2010; 2010:(1)397-402 https://doi.org/10.1182/asheducation-2010.1.397

McMillan R Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production. Hematol Oncol Clin North Am. 2009; 23:(6)1163-75 https://doi.org/10.1016/j.hoc.2009.08.008

Mutter WP, Karumanchi SA Molecular mechanisms of pre-eclampsia. Microvasc Res. 2008; 75:(1)1-8 https://doi.org/10.1016/j.mvr.2007.04.009

Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ Prospective study of placental angiogenic factors and maternal vascular function before and after pre-eclampsia and gestational hypertension. Circulation. 2010; 122:(5)478-87 https://doi.org/10.1161/CIRCULATIONAHA.109.895458

Özdemirci Ş, Başer E, Kasapoğlu T, Karahanoğlu E, Kahyaoglu I, Yalvaç S, Tapısız Ö Predictivity of mean platelet volume in severe preeclamptic women. Hypertens Pregnancy. 2016; 17:1-9 https://doi.org/10.1080/10641955.2016.1185113

Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, Holcberg G, Yerushalmi R Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2006; 128:(1–2)163-8 https://doi.org/10.1016/j.ejogrb.2005.12.031

Pourrat O, Coudroy R, Pierre F ADAMTS13 deficiency in severe postpartum HELLP syndrome. Br J Haematol. 2013; 163:(3)409-10 https://doi.org/10.1111/bjh.12494

Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012; 158:(3)323-35 https://doi.org/10.1111/j.1365-2141.2012.09167.x

Shamsi U, Saleem S, Nishter N Epidemiology and risk factors of preeclampsia; an overview of observational studies. Al Ameen J Med Sci. 2013; 6:(4)292-300

Sibai BM, Stella CL Diagnosis and management of atypical pre-eclampsia-eclampsia. Am J Obstet Gynecol. 2009; 200:(5)481.e1-481.e7 https://doi.org/10.1016/j.ajog.2008.07.048

Townsley DM Hematologic complications of pregnancy. Semin Hematol. 2013; 50:(3)222-31 https://doi.org/10.1053/j.seminhematol.2013.06.004

Turgut A, Demirci O, Demirci E, Uludoğan M Comparison of maternal and neonatal outcomes in women with HELLP syndrome and women with severe pre-eclampsia without HELLP syndrome. J Prenat Med. 2010; 4:(3)51-8

van Veen JJ, Nokes TJ, Makris M The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals. Br J Haematol. 2010; 148:(1)15-25 https://doi.org/10.1111/j.1365-2141.2009.07899.x

Platelets in pregnancy: Their role and function in disease

02 August 2016
9 min read
Volume 24 · Issue 8

Abstract

Platelets are critical to normal haemostasis and help limit blood loss following vascular injury. In pregnancy, they become increasingly important in preventing excessive bleeding during and immediately following birth. Platelets undergo several changes to adapt to the specific requirements of pregnancy and to facilitate a pro-thrombotic state. Despite the enhanced role of platelets in effective haemostasis, changes in platelet function may also be associated with adverse medical conditions. Such conditions range from mild (e.g. gestational thrombocytopaenia) to severe (e.g. pre-eclampsia and thrombotic thrombocytopaenic purpura). This article discusses changes in platelet function and their role in the development of pathological conditions during pregnancy.

Platelets are ‘anucleate’ cell fragments that circulate in the blood and are critical for haemostasis (Figure 1). They usually exist in a quiescent state but upon vascular injury they become activated and adhere to damaged vascular walls in order to limit bleeding (Linden, 2013). Conversely, defective platelet activity is associated with increased bleeding. During pregnancy, platelets undergo several changes to offset the increased blood loss during birth and the immediate postpartum period.

The usual range of platelet count is between 150–400 × 109/L, with a mean value around 260 × 109/L, although this can vary with age (Biino et al, 2013). Due to increased consumption in pregnancy, the platelet count falls, with statistically significant reductions noted in the third trimester. This fall is greater than reductions seen in both the first trimester and 8 weeks postpartum (Karlsson et al, 2014).

Register now to continue reading

Thank you for visiting British Journal of Midwifery and reading some of our peer-reviewed resources for midwives. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • Unlimited access to the latest news, blogs and video content

  • Monthly email newsletter